Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
83 studies found for:    "Bacterial meningitis"
Show Display Options
Rank Status Study
1 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
2 Completed Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Glycerol and paracetamol;   Drug: Paracetamol;   Drug: Placebo;   Drug: Paracetamol and glycerol;   Drug: Glycerol
3 Recruiting Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae
Condition: Meningitis, Bacterial
Intervention:
4 Active, not recruiting Infant Severe Sepsis and Bacterial Meningitis in Malawi
Condition: Infant Bacterial Meningitis
Intervention: Drug: Ceftriaxone v penicillin and gentamicin
5 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
6 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
7 Recruiting DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis;   Bacterial Meningitis
Interventions: Biological: DTaP-IPV/Hib Combined vaccine;   Biological: DTaP-IPV vaccine and Hib vaccine
8 Completed Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
9 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
10 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Conditions: Neurological Disorders;   Cerebral Malaria;   Bacterial Meningitis;   Central Nervous System Tuberculosis;   Neurosyphilis;   Cryptococcal Meningitis
Interventions: Device: Immunochromatographic HAT tests (DSD);   Device: Card Agglutination Trypanosoma Test;   Device: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics);   Device: TB 3-marker RDT (Tulip diagnostics);   Device: Cryptococcal Antigen Lateral Flow Assay (Immy)
11 Withdrawn Amikacin Penetration Into the Cerebrospinal Fluid
Conditions: Gram Negative Meningitis;   Post Traumatic Bacterial Meningitis
Intervention: Drug: Systemic and Intra-Thecal Amikacin Therapy
12 Completed Safety and Immunogencitiy Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)
Conditions: Neisseria Meningitidis (Bacterial Meningitis);   Invasive Pneumococcal Disease (IPD)
Interventions: Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)
13 Suspended Daptomycin in Pediatric Patients With Bacterial Meningitis
Conditions: Meningitis;   Gram-Positive Bacteria
Intervention: Drug: Daptomycin
14 Unknown  Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
15 Recruiting Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28
Conditions: Meningoccocal Disease,;   Meningococcal Meningitis
Interventions: Biological: rMenB + OMV vaccine (1 dose at study month zero);   Biological: rMenB + OMV vaccine (2 doses 1 month apart)
16 Recruiting Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Conditions: Seizures;   Pneumococcal Meningitis
Interventions: Drug: Phenytoin;   Drug: placebo
17 Completed
Has Results
Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years
Conditions: Meningococcal Infections;   Meningococcal Meningitis
Interventions: Biological: Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide;   Biological: Menactra®: Polysaccharide Diphtheria Toxoid Conjugate
18 Completed
Has Results
Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Interventions: Biological: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine;   Biological: Meningococcal (group B) multicomponent recombinant adsorbed vaccine;   Biological: Tdap
19 Completed Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults
Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine candidate;   Procedure: Blood draw
20 Completed Study to Evaluate GlaxoSmithKline (GSK) Biologicals’ MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers
Condition: Meningitis, Haemophilus
Interventions: Biological: MenC-TT;   Biological: Hib-MenC-TT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years